New drug combination attacks prostate cancer more effectively 

The drug combination works by simultaneously switching off two powerful growth signals that fuel prostate cancer.

New drug combination attacks prostate cancer on two fronts 

Men with particularly aggressive prostate cancers can be treated more effectively by combining an existing targeted medicine with an experimental drug, new research suggests.

Using both medications extended the time before prostate cancers progressed and spread further in men whose tumours lacked a gene known as PTEN.